Evaluation of Simplexa Flu A/B & RSV for Direct Detection of Influenza Viruses (A and B) and Respiratory Syncytial Virus in Patient Clinical Samples
Author(s) -
Musa Hindiyeh,
Liat Kolet,
Tal Meningher,
Merav Weil,
Ella Mendelson,
Michal Mandelboim
Publication year - 2013
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.00286-13
Subject(s) - virology , respiratory system , virus , paramyxoviridae , orthomyxoviridae , influenza a virus , medicine , mononegavirales , covid-19 , influenzavirus b , positive predicative value , predictive value , microbiology and biotechnology , biology , viral disease , disease , infectious disease (medical specialty)
We evaluated the performance of the Simplexa Flu A/B & RSV kit on 170 prospective respiratory samples using a modified protocol, supplied by the manufacturer, that eliminates the RNA extraction step. Overall, compared against our laboratory-developed assay, the assay's sensitivity, specificity, and positive and negative predictive values were 95.1%, 99.6%, 98.7%, and 98.6%, respectively.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom